Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
about
Why do some patients with type 1 diabetes live so long?Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.New frontiers in the treatment of diabetic dyslipidemiaSapium ellipticum (Hochst.) Pax Ethanol Leaf Extract Maintains Lipid Homeostasis in Streptozotocin-Induced Diabetic Rats.Evaluation of hypoglycemic effect of Morus alba in an animal model.Dyslipidaemia Associated with Type 2 Diabetics with Micro and Macrovascular Complications among GhanaiansTreatment approaches for diabetes and dyslipidemiaOverweight children with type 1 diabetes have a more favourable lipid profile than overweight non-diabetic children.Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetesTreatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes.Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?Regulation of signal transduction by HDL.Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control studyAssociation of lipoprotein lipase (LPL) single nucleotide polymorphisms with type 2 diabetes mellitus.Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?Vascular calcification in diabetes: mechanisms and implications.New insights into lipid metabolism in non-insulin-dependent diabetes mellitus.Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus.Antihyperglycemic and antihyperlipidemic effects of guar gum on streptozotocin-induced diabetes in male ratsEthnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus.Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations.Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.Alteration of lipid status and lipid metabolism, induction of oxidative stress and lipid peroxidation by 2,4-dichlorophenoxyacetic herbicide in rat liver.Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans.Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery.Effect of IGF-I therapy on VLDL apolipoprotein B100 metabolism in type 1 diabetes mellitus.The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling
P2860
Q26858877-236571C7-331C-4627-A0B7-2FCEE8A6665FQ33736145-CBBB788C-B826-4F19-A9A7-CE63CEDAB463Q33776236-B3E5F4CA-76DA-4DD5-905E-A20CAA864036Q33820068-00635A12-E0B0-4F32-B281-3FA42383AD28Q34501371-DA89A305-8BFA-41FB-97A2-27CC5BE66E58Q35184315-9DE70968-E8D7-43CD-B0E4-9EC20A900898Q35460295-55602490-4762-4ABD-B0D8-AC3A87C9E59CQ35772433-7F0D242A-5D47-403F-9FE9-8FC1B561ECE5Q36494412-1A9A7DC8-C360-4191-813D-C3F20D6A5684Q36623865-02B43B5E-1B1C-42D0-BF09-F3DA44910BDAQ36898042-16864812-32C8-4AE7-8FDD-BBCF38B97526Q37076473-2ED0DA85-840D-46C2-B364-D86D955C8F79Q37105165-DF69411D-20D7-4CF8-99C1-6439CC50FCE7Q37185048-B01F7379-C72E-4874-A959-32CFEF723201Q37807503-9AA7F2AD-306C-44FF-8CF0-9FDEB3E48F41Q38092767-7EB85101-05B1-4CCA-8012-7B5AFF0A379DQ41156132-095983EB-0B10-467F-9B35-AB55BB4F9843Q41156139-7DCE8978-AA86-47C3-922C-C0E575AC6B67Q41967648-BF164D90-0E95-43EF-8EBF-6CD4E999CFF8Q43687484-E70B68F9-D3BC-47C2-BC46-F7FFEE125C0FQ43918200-079BAEBD-2B54-4771-A13C-185B8DEC695AQ44058520-18DE6773-84B5-417C-B4C4-733572631420Q46382448-CF3C0EF7-C914-425D-86F4-25C139F632CDQ46743601-90276492-309B-4788-B93D-E930B17AA69CQ51384216-4399FC91-727E-484F-8013-21B01092B05EQ51447789-332F9F3E-F766-4379-A6AC-0283461AFEBDQ51543747-2DA2FF12-DC9C-4C70-83DA-A3D56EFA595DQ58209963-844692C4-DB7B-4478-B74F-9D13923BDC70
P2860
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
@ast
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
@en
type
label
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
@ast
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
@en
prefLabel
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
@ast
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus.
@en
P356
P1433
P1476
Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus
@en
P2093
Taskinen MR
P356
10.2337/DIAB.41.2.S12
P407
P478
41 Suppl 2
P577
1992-10-01T00:00:00Z